SELECT * FROM program_table WHERE category = 'Dermatologicals' AND parent_id IS NULL
Our Products
Generic Name
Tazarotene

Therapeutic area
Dermatologicals

Dosage Form
Topical gel

Usage
Indicated for the topical treatment of patients with facial acne vulgaris of mild to moderate severity. with facial acne vulgaris of mild to moderate severity. with facial acne vulgaris of mild to moderate severity.
Generic Name
Butenafine HCL

Therapeutic area
Dermatologicals

Dosage Form
Topical cream

Usage
Is indicated for the topical treatment of tinea pityriasis, tinea pedis, tinea corporis and tinea cruris.
Generic Name
Clobetasol propionate

Therapeutic area
Dermatologicals

Dosage Form
Topical ointment

Usage
For the treatment of more resistant dermatoses such as psoriasis, recalcitrant eczemas, lichen planus, discoid lupus erythematous and other skin conditions which don’t respond to less active steroids.
Generic Name
Clobetasol propionate

Therapeutic area
Dermatologicals

Dosage Form
Topical cream

Usage
For the treatment of more resistant dermatoses such as psoriasis, recalcitrant eczemas, lichen planus, discoid lupus erythematous and other skin conditions which don’t respond to less active steroids.
Generic Name
Dapson

Therapeutic area
Dermatologicals

Dosage Form
Topical gel

Usage
Indicated for the topical treatment of acne vulgaris
Generic Name
Calcipotriol 0.005gm/ 100gm and Betamethasone Dipropionate 0.064 gm /100gm (eq. to Betamethasone 0.05 gm /100gm )

Therapeutic area
Dermatologicals

Dosage Form
Ointment

Usage
Topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy in adults.
Generic Name
Elfornithine

Therapeutic area
Dermatologicals

Dosage Form
Topical cream

Usage
Indicated for slowing the growth of idiopathic unwanted facial hair in women.
Generic Name
Crisaborole

Therapeutic area
Dermatologicals

Dosage Form
Topical Ointment

Usage
Mild to moderate Atopic dermatitis
Generic Name
Fusidic acid 2gm/100gm

Therapeutic area
Dermatologicals

Dosage Form
Topical Gel

Usage
Indicated either alone or in combination with systemic therapy in the treatment of primary and secondary skin infections caused by sensitive strains of Staphylococcus aureus, Streptococcus spp and Corynebacterium minutissimum.
Generic Name
Silver sulphadiazine +Sodium hyaluronate

Therapeutic area
Dermatologicals

Dosage Form
Topical cream

Usage
Prophylaxis and treatment of infected skin lesions: wounds, ulcers, abrasions and burns of any degree.
Generic Name
Ruxolitinib

Therapeutic area
Dermatologicals

Dosage Form
Topical cream

Usage
Nonsegmental vetiligo / Atopic dermatitis
Generic Name
Hydrocortisone 17? butyrate

Therapeutic area
Dermatologicals

Dosage Form
Topical Lipocream

Usage
Treatment of eczema, psoriasis and dermatitis.
Generic Name
Extract Cepae fluid, Heparin sodium, Allantoin.

Therapeutic area
Dermatologicals

Dosage Form
Topical gel

Usage
Hypertrophic, Keloid, movement-restricting and cosmetically disfiguring scars after operations, amputations, burns and accidents.
Generic Name
Tacrolimus

Therapeutic area
Dermatologicals

Dosage Form
Topical ointment

Usage
Treatment of moderate to severe atopic dermatitis.
Generic Name
Fluocinolone + Hydroquinone + Trerinoin

Therapeutic area
Dermatologicals

Dosage Form
Topical cream

Usage
Indicated for the short term treatment of moderate to severe melasma of the face in the presence of measures for sun avoidance including the use of sun screens.
How drugs are made?
Pharmaceutical products are made through complex processes involving research, development, manufacturing, and quality control. Here's a simplified overview
Let’s work together
Export Capabilites
Marcyrl Pharmaceutical Industries, an Egyptian pharmaceutical manufacturer, has secured investment from Development Partners International (DPI) and Amethis. They focus on specialty generics, to improve access to critical care drugs across Africa. Marcyrl’s growth includes expanding its product portfolio and addressing the demand for affordable specialty generics in Africa. The investment underscores the significance of the pharmaceutical sector and Marcyrl’s commitment to bridging healthcare gaps in the continent.

Capitalizing on our EU-approved GMP sites, Marcyrl Pharmaceutical Industries is exporting a wide range portfolio of medicines to 23 export markets including GCC, LEVANT, and AFRICA

Our ambitious plan to expand our export business in Africa, CIS, GCC, and LATAM.